Global Stock News

  • March 1, 2026
Facebook-f X-twitter Linkedin-in Instagram

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Share this article

More News

Scroll to Top